Coon W W, Dabich L, Votaw M L
Arch Surg. 1980 Apr;115(4):401-4. doi: 10.1001/archsurg.1980.01380040033005.
Secondary operative staging (diagnostic celiotomy after initial lymphoma staging and treatment) is of value in selected patients with Hodgkin's disease if, after appropriate clinical staging, there remains a reasonable doubt concerning the presence of residual or recurrent lymphoma. In our experience, although signs indicating possible recurrence were present in 35 patients, only 20 of these were found to have Hodgkin's disease within the abdomen at operation. These findings allowed us to restrict our intensive therapy to those with documented disease and to withhold potentially harmful treatment from the remaining subjects who on follow-up have shown no evidence to date of subsequent recurrence within the abdomen. The utilization of secondary operative staging in ten patients with non-Hodgkin's lymphoma has been less productive and is not recommended on the basis of our limited current experience.
对于部分霍奇金病患者,如果在进行适当的临床分期后,对残留或复发性淋巴瘤的存在仍存在合理怀疑,二次手术分期(初始淋巴瘤分期和治疗后的诊断性剖腹术)是有价值的。根据我们的经验,尽管35例患者出现了可能复发的体征,但其中只有20例在手术中被发现腹部患有霍奇金病。这些发现使我们能够将强化治疗限制在有确诊疾病的患者身上,并避免对其余患者进行可能有害的治疗,这些患者在随访中至今未显示腹部有后续复发的证据。在10例非霍奇金淋巴瘤患者中应用二次手术分期的效果较差,基于我们目前有限的经验,不建议使用。